Neutrophil aggregation and swelling induced by chemotactic agents

Area of Science:

• Immunology
• Cell Biology

Background:

• Neutrophils play a key role in immune responses.
• Neutropenia, a decrease in neutrophil count, can result from exposure to certain agents.
• The mechanisms underlying neutrophil aggregation and volume changes induced by chemotactic agents require further elucidation.

Purpose of the Study:

• To develop and validate an assay for measuring neutrophil aggregation and cell size.
• To investigate the effects of chemotactically active agents on neutrophil behavior.
• To explore the relationship between neutrophil aggregation, cell volume changes, and neutropenia.

Main Methods:

• Utilized a Coulter Counter with a mean cell volume computer and volume channalyzer.
• Developed a novel assay to measure neutrophil aggregation and cell size.
• Administered chemotactically active agents to rabbit neutrophils in suspension.

Main Results:

• Several chemotactic agents rapidly induced reversible neutrophil aggregation.
• The aggregating activity of these agents correlated with their chemotactic and neutropenia-inducing potencies.
• Chemotactic agents also induced a slower, irreversible increase in neutrophil volume, independent of aggregation.
• This volume increase may be linked to pseudopodia formation and membrane ruffling.

Conclusions:

• Neutrophil aggregation induced by chemotactic agents may contribute to neutropenia.
• Chemotactic agents can alter neutrophil size through a process distinct from aggregation.
• The developed assay provides a valuable tool for studying neutrophil responses to chemotactic stimuli.